Senator Investment Group LP Argenx Se Transaction History

Senator Investment Group LP

  • $2.03 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$334.23 - $403.65 $5.01 Million - $6.05 Million
-15,000 Reduced 37.5%
25,000 $9.31 Million
Q4 2022

Feb 13, 2023
BUY
$342.17 - $402.31 $13.7 Million - $16.1 Million
40,000 New
40,000 $15.2 Million
Q2 2022

Aug 15, 2022
BUY
$269.58 - $378.88 $13.5 Million - $18.9 Million
50,000 New
50,000 $18.9 Million

Others Institutions Holding ARGX

# of Institutions
400
Shares Held
30.9M
Call Options Held
376K
Put Options Held
489K
View Full List

About ARGENX SE

ARGX Quotes by TradingView
  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Senator Investment Group LP Portfolio

Follow Senator Investment Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Senator Investment Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Senator Investment Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email